ATARA BIOTHERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Foreign Currency Transaction Gain (Loss), before Tax of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2018-02-27
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2017-03-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2016-06-30 was $38.00K.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2016-03-31 was -$42.00K.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2017 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2016 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2015 was -$94.00K.
- ATARA BIOTHERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2014 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | ||
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | ||
| 2016-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$4.00K 10-Q · filed 2017-08-07 | |
| 2016-03-31 | -$42.00K 10-Q · filed 2017-05-04 | ||
| 2015-12-31 | -$94.00K 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |